The pundits, major media, and many in Congress got it wrong when it came to the election.
But that’s not what I want to talk about right now.
What I want to focus on, instead, are the new profit opportunities that have presented themselves over the past 48 hours.
There are three sectors in particular that couldn’t be happier about President-elect Trump.
And the first one may surprise you…
How Tax, Financial Regulatory, and Health Care Reforms Could Create the Most Lucrative Trading Opportunities
The markets were expected to tumble into a downward freefall after Donald Trump was declared the Presidential-elect. But though Dow futures dropped by over 800 points at one point, the markets stunned us by regaining their footing to rally higher on Wednesday. And with the word being that we can expext tax, regulatory, and health care reforms, a door of new profit opportunities has opened.
So here are the three sectors that stand to make big gains following the Trump’s election…
- Health Care Stocks
I realize you might be reading this and thinking it’s a typo – it’s not.
Although health care stocks were “supposed” to drop following the results, but we saw yet another election surprise. Health insurance stocks did drop on Wednesday, but actual health care stocks are embracing Trump’s victory because of the priority in repealing and replacing the Affordable Care Act (ACA).
Big insurers, like Aetna and UnitedHealth, have already pulled out of the ACA. Now, with a Trump presidency, the prospect of having state lines removed would create more competition for health care companies – which would drive up profits.
And one of the largest health care ETFs, Health Care Select Sector SPDR ETF (NYSE: XLV), could lead to some very nice profits. Take a look at it’s the bounce in price from just one week ago…
- Biotech Stocks
Fears of Clinton winning and taking strict action on the prices of pharmaceuticals had been putting a lot of pressure on the pharmaceutical and biotechnology industry.
On Wednesday, pharma and biotech stocks skyrocketed, with the NASDAQ Biotechnology Index climbing 9% – breaking its record for largest single-day gains in over eight years. Prior to Trump’s victory, biotech shares on the NASDAQ had lost more than a fourth of their value since September.
Now it’s still unclear how tough the next administration will be on drug prices, with many Republicans also pushing for low drug prices in light of the EpiPen issue. But one thing’s for certain right now… pharmaceuticals and biotechnology investors have far less to fear and have some great profit opportunities in front of them.
And one way to play it is on the largest biotech stock ETF in the world, iShares NASDAQ Biotechnology ETF, (NYSE: IBB). Here’s a look it’s price movement since September, which shows its upward climb after the election results became clear:
- Financial Stocks
This should come as no surprise to you, but the big banks are happy about a Trump win. Though the sector fell, along with the rest of the markets, after the shocking election results, bank stocks soard on Wednesday. The KBW NASDAQ Bank Index, for example, posted its biggest one day-gain since February of nearly 5%.
Trump’s already criticized the Dodd-Frank financial reform legislation and has favored lighter regulations on the big banks and Wall Street. On top of that, if the Fed does go through with raising interest rates by the end of the year, you’re looking at very lucrative opportunities in the financial sector.
And one such opportunity is playing the Financial Services Select Sector SPDR (NYSE: XLFS), one of the largest financial sector ETFs in the markets. Here’s a look at it’s upward price movement since mid-September:
To your continued success,